Gina M. Badalato

Gina Badalato practices at Operating Room Allen Hospital - HOPD in New York, New York.

Gina Badalato's NPI, 1932363546, was assigned on July 12, 2008. Gina Badalato graduated from Vagelos College of Physicians and Surgeons in 2007. Gina Badalato holds New York license 249240-1.

Gina Badalato's primary practice is Operating Room Allen Hospital - HOPD, at 5141 Broadway, New York, NY 10034.

Gina Badalato's primary practice is Operating Room Allen Hospital - HOPD in New York, New York. Gina Badalato is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Gina Badalato to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Gina Badalato practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Gina Badalato's primary specialty in the NPI Registry, under taxonomy code 208800000X. Gina Badalato is board certified in urology by the American Board of Urology. Dmand AI has Gina Badalato's licenses on file in 2 states: New York and Florida.

Dmand AI lists enlarged prostate, kidney stone disease, urinary endoscopy, urine flow blockage and UTI among the conditions Gina Badalato treats.

CMS data shows 273 Medicare services from Gina Badalato across 5 procedure codes in 2024, for 153 Medicare patients. Medicare paid $26,791 for them. Every service was in an office.

CMS counts 153 Medicare patients who saw Gina Badalato in 2024. The largest group is 65 to 74, with 56 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 46% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Gina Badalato's median patient age at 64, with 73% women.

In 2024, Gina Badalato wrote 1,253 Medicare Part D claims for 321 patients. 54% of them were for generic drugs. CMS names the drug for 1,142 of them, across 10 drugs with 11 or more claims each, at $372,570 in total drug cost. In 2023, CMS named 886 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Gina Badalato for performance year 2024, reported through an alternative payment model (APM). Gina Badalato accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Gina Badalato as offering telehealth.

Dmand AI links 81 papers to Gina Badalato, published from 2009 to 2025. 2023 was the busiest year, with 12. The most frequent topics are Urology, Internship and Residency and Education, Medical, Graduate. Gina Badalato has published most often in Urology. Gina Badalato's most frequent co-authors are James M. McKiernan, MD, Christopher Burch Anderson, MD and Gary Evan Lemack, MD.

CMS Open Payments shows 100 general payments to Gina Badalato from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Sumitomo Pharma America, Inc. paid the most, $848.

Gina Badalato graduated from Vagelos College of Physicians and Surgeons in 2007.

Gina Badalato is in network with 16 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.